Colgate Palmolive Co. (CL) financials: revenue, earnings and cash flow
Fiscal 2016–2025 + TTM · from SEC filings · data as of November 13, 2026
Summary
Colgate Palmolive’s revenue went from $15.2B in fiscal 2016 to $20.4B in fiscal 2025, growth of about 3.3% a year.
Net income in fiscal 2025 was $2.1B, a net margin of 10.5%; the best year in this period was 2024 with $2.9B.
Over the twelve months to September 30, 2026, revenue was $21.3B and net income $2.1B.
Free cash flow was $3.6B in fiscal 2025 and positive in 10 of the 10 years shown.
The diluted share count fell 10% over the period (buybacks).
Revenue, profit and cash flow by year
Income statement
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $21.3B | $20.4B | $20.1B | $19.5B | $18.0B | $17.4B | $16.5B | $15.7B | $15.5B | $15.5B | $15.2B |
| Gross profit | $12.9B | $12.3B | $12.2B | $11.3B | $10.2B | $10.4B | $10.0B | $9.3B | $9.2B | $9.3B | $9.1B |
| Operating income | $3.2B | $3.3B | $4.3B | $4.0B | $2.9B | $3.3B | $3.9B | $3.6B | $3.7B | $3.7B | $4.0B |
| Net income | $2.1B | $2.1B | $2.9B | $2.3B | $1.8B | $2.2B | $2.7B | $2.4B | $2.4B | $2.0B | $2.4B |
| EPS (diluted) | $2.56 | $2.63 | $3.51 | $2.77 | $2.13 | $2.55 | $3.14 | $2.75 | $2.75 | $2.28 | $2.72 |
| R&D | — | $366M | $355M | $343M | $320M | $307M | $290M | $281M | $277M | $285M | $289M |
| Revenue growth | — | +1.4% | +3.3% | +8.3% | +3.1% | +5.8% | +5.0% | +1.0% | +0.6% | +1.7% | −5.2% |
Cash flow
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $4.4B | $4.2B | $4.1B | $3.7B | $2.6B | $3.3B | $3.7B | $3.1B | $3.1B | $3.1B | $3.1B |
| Capital spending | -$577M | -$564M | -$561M | -$705M | -$696M | -$567M | -$409M | -$335M | -$436M | -$553M | -$593M |
| Free cash flow | $3.8B | $3.6B | $3.5B | $3.0B | $1.9B | $2.8B | $3.3B | $2.8B | $2.6B | $2.5B | $2.5B |
| Dividends paid | $1.8B | $1.8B | $1.8B | $1.7B | $1.7B | $1.7B | $1.7B | $1.6B | $1.6B | $1.5B | $1.5B |
| Buybacks | $1.3B | $1.2B | $1.7B | $1.1B | $1.3B | $1.3B | $1.5B | $1.2B | $1.2B | $1.4B | $1.3B |
| Stock-based pay | $169M | $155M | $135M | $122M | $125M | $135M | $107M | $100M | $109M | $127M | $123M |
Balance sheet
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | — | $1.4B | $1.3B | $1.1B | $775M | $832M | $888M | $883M | $726M | $1.5B | $1.3B |
| Debt | — | $8.6B | $8.5B | $8.8B | $9.3B | $7.8B | $8.0B | $8.2B | $6.4B | $6.6B | $6.5B |
| Equity | — | $54M | $212M | $609M | $401M | $609M | $743M | $117M | -$102M | -$60M | -$243M |
| Total assets | — | $16.3B | $16.0B | $16.4B | $15.7B | $15.0B | $15.9B | $15.0B | $12.2B | $12.7B | $12.1B |
| Shares (diluted) | 800M | 811M | 823M | 829M | 839M | 848M | 859M | 861M | 873M | 888M | 898M |
Margins and returns
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 60.6% | 60.1% | 60.5% | 58.2% | 57.0% | 59.6% | 60.8% | 59.4% | 59.4% | 60.1% | 60.0% |
| Operating margin | 14.8% | 16.2% | 21.2% | 20.5% | 16.1% | 19.1% | 23.6% | 22.7% | 23.8% | 24.0% | 26.0% |
| Net margin | 9.6% | 10.5% | 14.4% | 11.8% | 9.9% | 12.4% | 16.4% | 15.1% | 15.4% | 13.1% | 16.1% |
| FCF margin | 17.8% | 17.8% | 17.6% | 15.6% | 10.3% | 15.8% | 20.1% | 17.8% | 16.9% | 16.2% | 16.8% |
| ROIC | — | 28.4% | 37.7% | 30.8% | 22.1% | 30.0% | 35.0% | 32.6% | 43.6% | 35.5% | 43.6% |
| ROE | — | 3948.1% | 1362.7% | 377.7% | 445.1% | 355.7% | 362.7% | 2023.1% | -2352.9% | -3373.3% | -1004.5% |
Frequently asked questions
What is Colgate Palmolive’s annual revenue?
$20.4B in fiscal 2025 and $21.3B over the twelve months to September 30, 2026.
How much profit does Colgate Palmolive make?
Net income was $2.1B in fiscal 2025 (net margin 10.5%).
Is Colgate Palmolive’s revenue growing?
Yes: revenue rose 1.4% in fiscal 2025 compared with the year before.
From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.